Cargando…
Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
Peritoneal dissemination is the primary metastatic route of ovarian cancer (OvCa), and is often accompanied by the accumulation of ascitic fluid. The peritoneal cavity is lined by mesothelial cells (MCs), which can be converted into carcinoma‐associated fibroblasts (CAFs) through mesothelial‐to‐mese...
Autores principales: | Rynne‐Vidal, Angela, Au‐Yeung, Chi Lam, Jiménez‐Heffernan, José A, Pérez‐Lozano, María Luisa, Cremades‐Jimeno, Lucía, Bárcena, Carmen, Cristóbal‐García, Ignacio, Fernández‐Chacón, Concepción, Yeung, Tsz Lun, Mok, Samuel C, Sandoval, Pilar, López‐Cabrera, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468005/ https://www.ncbi.nlm.nih.gov/pubmed/28247413 http://dx.doi.org/10.1002/path.4889 |
Ejemplares similares
-
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
por: Rynne-Vidal, Angela, et al.
Publicado: (2015) -
Functional Relevance of the Switch of VEGF Receptors/Co-Receptors during Peritoneal Dialysis-Induced Mesothelial to Mesenchymal Transition
por: Pérez-Lozano, María Luisa, et al.
Publicado: (2013) -
Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
por: Pascual-Antón, Lucía, et al.
Publicado: (2021) -
Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?
por: Loureiro, Jesús, et al.
Publicado: (2013) -
Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013)